Literature DB >> 1594185

Combined silicone and fluorosilicone oil tamponade (double filling) in the management of complicated retinal detachment.

F Bottoni1, P Arpa, P Vinciguerra, S Zenoni, V De Molfetta.   

Abstract

We evaluated the use of simultaneous double filling with polydimethylsiloxane (PDMS) and fluorosilicone (FSiO) in the repair of complicated retinal detachment in 12 selected cases. Initial retinal reattachment was achieved in all cases. Proliferative vitreoretinopathy (PVR) recurred in 10 patients (83%), 6 of which showed partial retinal detachment. Inferior and superior postoperative residual free spaces were abolished by this procedure, but a new residual fluid space was created, lying horizontally between the bubbles and expanding in a triangular shape nasally to the optic disk and temporally to the macula. Overall, 9 of 10 eyes with postoperative PVR had proliferation involving these areas. These findings support the concept that 'compartmentalization' is of major importance in determining postoperative cell proliferation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1594185     DOI: 10.1159/000310273

Source DB:  PubMed          Journal:  Ophthalmologica        ISSN: 0030-3755            Impact factor:   3.250


  11 in total

1.  A pilot study on the use of a perfluorohexyloctane/silicone oil solution as a heavier than water internal tamponade agent.

Authors:  D Wong; J C Van Meurs; T Stappler; C Groenewald; I A Pearce; J N McGalliard; E Manousakis; E N Herbert
Journal:  Br J Ophthalmol       Date:  2005-06       Impact factor: 4.638

2.  A pilot study on the use of silicone oil-RMN3 as heavier-than-water endotamponade agent.

Authors:  Stanislao Rizzo; Federica Genovesi-Ebert; Claudia Belting; Andrea Vento; Federica Cresti
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-06-28       Impact factor: 3.117

3.  Perfluorohexyloctane as a long-term vitreous tamponade in the experimental animal. Experimental perfluorohexyloctane substitution.

Authors:  D Zeana; J Becker; R Kuckelkorn; B Kirchhof
Journal:  Int Ophthalmol       Date:  1999       Impact factor: 2.031

4.  Tamponade properties of double-filling with perfluorohexyloctane and silicone oil in a model eye chamber.

Authors:  Edward Herbert; Theodor Stappler; Carolina Wetterqvist; Rachel Williams; David Wong
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-12-18       Impact factor: 3.117

5.  Two-staged surgery as an alternative to buckle-vitrectomy for rhegmatogenous retinal detachment complicated by choroidal detachment.

Authors:  Naresh Babu; Piyush Kohli; Karthik Kumar; Renu P Rajan; Girish Baliga; Sagnik Sen; N O Ramachandran; S Bhavani; Kim Ramasamy
Journal:  Int Ophthalmol       Date:  2020-08-28       Impact factor: 2.031

6.  Perfluorocarbon liquids as postoperative short-term vitreous substitutes in complicated retinal detachment.

Authors:  F Bottoni; M Sborgia; P Arpa; N De Casa; E Bertazzi; M Monticelli; V De Molfetta
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1993-11       Impact factor: 3.117

7.  Interactions of perfluorocarbon liquids and silicone oil as characterized by mass spectrometry.

Authors:  Thomas R Friberg; Peter E Siska; Kasi Somayajula; John Williams; Andrew W Eller
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-09-11       Impact factor: 3.117

Review 8.  The concept of heavy tamponades-chances and limitations.

Authors:  Antonia M Joussen; David Wong
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-06-11       Impact factor: 3.117

9.  Ocular tolerance and efficacy of short-term tamponade with double filling of polydimethyloxane and perfluoro-n-octane.

Authors:  Stefano Zenoni; Mario R Romano; Sonia Palmieri; Natalia Comi; Edoardo Fiorentini; Piero Fontana
Journal:  Clin Ophthalmol       Date:  2011-04-06

10.  Sandwich technique using a combination of perfluoropropane and silicone oil for inferior retinal detachment.

Authors:  Sumit Randhir Singh; Deven Dhurandhar; Jay Chhablani
Journal:  Indian J Ophthalmol       Date:  2018-07       Impact factor: 1.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.